What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to publicly disclose Schering-Plough Corporation's financial results for the third quarter of 2002, including sales and earnings, as well as provide supplementary product sales data. This is done in compliance with Regulation FD to ensure broad public dissemination of material information.

What specific financial information is being released?

The filing includes a press release that reports on Schering-Plough's sales and earnings for the third quarter of 2002. Additionally, separate product sales data for the same period is provided.

Where can investors find the detailed financial information mentioned in the filing?

Investors can find the detailed financial information by accessing Exhibits 99.1 (the press release) and 99.2 (product sales data) that are attached to this 8-K filing.

Is this filing from Merck & Co., Inc. (MRK) as indicated in the prompt?

No, despite the user prompt's mention of Merck & Co., Inc. (MRK), this 8-K filing is from Schering-Plough Corporation, as clearly stated on the form itself and in the exhibit details.

MRK 8-K SEC Disclosure — Oct 24, 2002

Summary

This 8-K filing from Schering-Plough Corporation (note: the user prompt incorrectly identified the company as Merck & Co., Inc.) on October 24, 2002, primarily serves to disclose financial information and exhibits related to the company's performance. It includes a press release detailing third-quarter 2002 sales and earnings, alongside specific product sales data. For investors, the key takeaway is the release of updated financial performance metrics for the third quarter of 2002. The attached press release (Exhibit 99.1) and product sales data (Exhibit 99.2) would provide crucial insights into the company's revenue generation, profitability, and the performance of its product portfolio during the specified period. Investors should carefully review these exhibits to assess Schering-Plough's current financial health and operational trends.

Key Highlights

1Schering-Plough Corporation filed an 8-K on October 24, 2002.
2The filing is related to the company's third-quarter 2002 financial results.
3Exhibit 99.1 is a press release announcing third-quarter 2002 sales and earnings.
4Exhibit 99.2 provides additional product sales data for the same period.
5The report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
6The filing includes information under Item 7 (Financial Statements and Exhibits) and Item 9 (Regulation FD Disclosure).

Merck & Co., Inc. 8-K Report (Oct 24, 2002)

Summary

Key Highlights

Frequently Asked Questions